New Biopharmaceuticals Study Results from Brigham and Women's Hospital Described (Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides Difficile Infection).

MLA

“New Biopharmaceuticals Study Results from Brigham and Women’s Hospital Described (Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides Difficile Infection).” Genomics & Genetics Weekly, Nov. 2024, p. 1545. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180593394&authtype=sso&custid=ns315887.

APA

New Biopharmaceuticals Study Results from Brigham and Women’s Hospital Described (Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides Difficile Infection). (2024). Genomics & Genetics Weekly, 1545.

Chicago

“New Biopharmaceuticals Study Results from Brigham and Women’s Hospital Described (Rational Design of Live Biotherapeutic Products for the Prevention of Clostridioides Difficile Infection).” 2024. Genomics & Genetics Weekly, November, 1545. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=180593394&authtype=sso&custid=ns315887.